HomeInsightsStock Comparison

Madhusudan Securities Ltd vs Novelix Pharmaceuticals Ltd Stock Comparison

Madhusudan Securities Ltd vs Novelix Pharmaceuticals Ltd Stock Comparison

Last Updated on: Aug 02, 2025

Key Highlights

  • The Latest Trading Price of Madhusudan Securities Ltd is ₹ 20.22 as of 01 Aug 15:30.
  • The P/E Ratio of Madhusudan Securities Ltd is 0 as of March 2020 .The P/E Ratio of Novelix Pharmaceuticals Ltd is 0 as of March 2020.
  • The Market Cap of Madhusudan Securities Ltd is ₹ 0 crore as of March 2020 .The Market Cap of Novelix Pharmaceuticals Ltd is ₹ 1.57 crore as of March 2020.
  • The revenue of Madhusudan Securities Ltd for the Mar '25 is ₹ 0.04 crore as compare to the Dec '24 revenue of ₹ 0.02 crore. This represent the growth of 100% The revenue of Novelix Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Madhusudan Securities Ltd for the Mar '25 is ₹ -0.13 crore as compare to the Dec '24 ebitda of ₹ -0.18 crore. This represent the decline of -27.78% The ebitda of Novelix Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Madhusudan Securities Ltd changed from ₹ 0.01 crore to ₹ -0.13 crore over 6 quarters. This represents a CAGR of NaN% The net profit of Novelix Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Madhusudan Securities Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Novelix Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

PE

Market Cap

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Madhusudan Securities Ltd

  • Madhusudan Securities Limited was incorporated in 1982.
  • Earlier, the Company was known as Madhusudan Investments Ltd. The company got its present name on September 29, 1995.
  • Earlier, the Company was engaged in the business of garments, fabrics, accessories, etc. During the year 2011, the Company had changed its Main Object to deal with Readymade or made to measure garments as regards the takeover of Business of Weekender from Primus Retail Private Limited vide Agreement dated 04 February, 2011.
  • The founder promoter Mr. K. S. Reddy and associates had transferred/ sold their shareholdings to Mr. Salim P. Govani and his Associates.
  • The new acquirer Mr. Salim P. Govani also acquired 20% shares by offering existing shareholders Rs. 76/- per share to increase his promoter shareholding.

About Novelix Pharmaceuticals Ltd

  • Trimurthi Limited was formerly incorporated on December 13, 1994 with the name Trimurthi Securities Ltd. The name of the Company thereafter got changed from Trimurthi Securities Ltd to Trimurthi Drugs & Pharmaceuticals Ltd. In September 2006, as per the Scheme of Arrangement, the erstwhile Trimurthi Drugs & Pharmaceuticals Ltd amalgamated with the Company.
  • Also, the name of the Company was changed to Trimurthi Drugs & Pharmaceuticals Ltd and again to Trimurthi Limited in May, 2016. Initially, the company was engaged in finance and investments in securities.
  • They ceased their operations due to the high volatility in the markets and voluntarily got de-registered as Non-Banking financial company.
  • Thereafter, the company explored the possibilities of entering into pharmaceutical and drug industry by way of diversification.

Madhusudan Securities Ltd News Hub

News

Madhusudan Securities schedules board meeting

Madhusudan Securities will hold a meeting of the Board of Directors of the Company on 29 M...

Read more

22 May 2025 15:57

News

Madhusudan Securities to convene board meeting

Madhusudan Securities will hold a meeting of the Board of Directors of the Company on 13 F...

Read more

04 Feb 2025 10:59

News

Madhusudan Securities to table results

Madhusudan Securities will hold a meeting of the Board of Directors of the Company on 14 N...

Read more

07 Nov 2024 20:05

News

Madhusudan Securities to convene AGM

Madhusudan Securities announced that the 41th Annual General Meeting (AGM) of the company ...

Read more

23 Sep 2024 17:54

News

Madhusudan Securities to declare Quarterly Result

Madhusudan Securities will hold a meeting of the Board of Directors of the Company on 13 A...

Read more

05 Aug 2024 14:30

News

Madhusudan Securities schedules board meeting

Madhusudan Securities will hold a meeting of the Board of Directors of the Company on 27 M...

Read more

22 May 2024 17:47

Novelix Pharmaceuticals Ltd News Hub

News

Novelix Pharmaceuticals to conduct board meeting

Novelix Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 24...

Read more

21 Jun 2025 15:28

News

Novelix Pharmaceuticals to convene board meeting

Novelix Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 27...

Read more

21 May 2025 16:50

News

Novelix Pharmaceuticals to convene EGM

Novelix Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Comp...

Read more

15 Apr 2025 10:33

News

Trimurthi to table results

Trimurthi will hold a meeting of the Board of Directors of the Company on 12 February 2025...

Read more

08 Feb 2025 10:47

News

Trimurthi to announce Quarterly Result

Trimurthi will hold a meeting of the Board of Directors of the Company on 13 November 2024...

Read more

09 Nov 2024 17:04

News

Trimurthi revises board meeting date

Trimurthi has revised the meeting of the Board of Directors which was scheduled to be held...

Read more

14 Oct 2024 10:29

SWOT Analysis Of Novelix Pharmaceuticals Ltd

Strength

0

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Madhusudan Securities Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Novelix Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Madhusudan Securities Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Madhusudan Securities Ltd and Novelix Pharmaceuticals Ltd

Which company has a larger market capitalization, Madhusudan Securities Ltd or Novelix Pharmaceuticals Ltd?

Market cap of Madhusudan Securities Ltd is 22 Cr while Market cap of Novelix Pharmaceuticals Ltd is 102 Cr

What are the key factors driving the stock performance of Madhusudan Securities Ltd and Novelix Pharmaceuticals Ltd?

The stock performance of Madhusudan Securities Ltd and Novelix Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Madhusudan Securities Ltd and Novelix Pharmaceuticals Ltd?

As of August 2, 2025, the Madhusudan Securities Ltd stock price is INR ₹20.22. On the other hand, Novelix Pharmaceuticals Ltd stock price is INR ₹41.14.

How do dividend payouts of Madhusudan Securities Ltd and Novelix Pharmaceuticals Ltd compare?

To compare the dividend payouts of Madhusudan Securities Ltd and Novelix Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions